Kayyem Jon Faiz
CIK 0001366268 Name as filed on the most recent filing
Filed as Kayyem Jon Faiz (83)
131 transaction lines · from 83 filings · filed 2007-11-02 to 2024-11-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Inhibrx Biosciences, Inc. 3 filings
- ISSUER Inhibrx, Inc. 4 filings
- ISSUER Biodesix Inc 1 filings
- ISSUER GenMark Diagnostics, Inc. 57 filings
- ISSUER Repros Therapeutics Inc. 18 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
87 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-11-20 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 18,750 acquired | 14.19 | 266,101.88 | Form 4, filing 0002007919-24-000064 | |
| 2024-11-20 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 18,750 acquired | 14.19 | 266,101.88 | Form 4, filing 0002007919-24-000064 | |
| 2024-11-19 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 34,843 acquired | 14.23 | 495,707.88 | Form 4, filing 0002007919-24-000064 | |
| 2024-11-19 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 34,843 acquired | 14.23 | 495,707.88 | Form 4, filing 0002007919-24-000064 | |
| 2024-06-05 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 49,284 acquired | 17.23 | 849,163.32 | Form 4, filing 0002007919-24-000008 | |
| 2024-06-05 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 8,265 acquired | 17.89 | 147,860.85 | Form 4, filing 0002007919-24-000008 | |
| 2024-06-04 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 65,337 acquired | 17.44 | 1,139,477.28 | Form 4, filing 0002007919-24-000006 | |
| 2024-06-04 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 23,726 acquired | 18.24 | 432,762.24 | Form 4, filing 0002007919-24-000006 | |
| 2024-06-03 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 80,738 acquired | 17.90 | 1,445,210.20 | Form 4, filing 0002007919-24-000006 | |
| 2024-06-03 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 46,792 acquired | 16.61 | 777,215.12 | Form 4, filing 0002007919-24-000006 | |
| 2024-05-31 |
Inhibrx Biosciences, Inc. INBX |
P, Open-market purchase | 70,193 acquired | 16.14 | 1,132,915.02 | Form 4, filing 0002007919-24-000006 | |
| 2023-01-23 |
Inhibrx, Inc. INBX |
S, Open-market sale | 9,500 disposed | 25.26 | 239,999.45 | Form 4, filing 0001739614-23-000008 | |
| 2022-12-21 |
Inhibrx, Inc. INBX |
S, Open-market sale | 7,541 disposed | 26.87 | 202,591.23 | Form 4, filing 0001739614-22-000132 | |
| 2022-12-21 |
Inhibrx, Inc. INBX |
S, Open-market sale | 1,959 disposed | 27.61 | 54,087.79 | Form 4, filing 0001739614-22-000132 | |
| 2022-11-21 |
Biodesix Inc BDSX |
P, Open-market purchase | 173,913 acquired | 1.15 | 199,999.95 | Form 4, filing 0001140361-22-042596 | |
| 2022-11-21 |
Inhibrx, Inc. INBX |
S, Open-market sale | 6,767 disposed | 30.12 | 203,819.33 | Form 4, filing 0001739614-22-000126 | |
| 2022-11-21 |
Inhibrx, Inc. INBX |
S, Open-market sale | 2,733 disposed | 29.33 | 80,153.15 | Form 4, filing 0001739614-22-000126 | |
| 2022-10-21 |
Inhibrx, Inc. INBX |
S, Open-market sale | 5,928 disposed | 30.58 | 181,254.53 | Form 4, filing 0001739614-22-000109 | |
| 2022-10-21 |
Inhibrx, Inc. INBX |
S, Open-market sale | 3,572 disposed | 29.39 | 104,977.15 | Form 4, filing 0001739614-22-000109 | |
| 2018-02-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 148 disposed | 5.13 | 759.24 | Form 4, filing 0001487371-18-000017 | |
| 2017-12-04 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 135 disposed | 4.70 | 634.50 | Form 4, filing 0001487371-17-000251 | |
| 2017-11-20 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 1,269 disposed | 4.74 | 6,015.06 | Form 4, filing 0001487371-17-000240 | |
| 2017-11-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 135 disposed | 7.24 | 977.40 | Form 4, filing 0001487371-17-000227 | |
| 2017-09-05 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 133 disposed | 9.75 | 1,296.75 | Form 4, filing 0001487371-17-000190 | |
| 2017-08-21 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 1,277 disposed | 9.45 | 12,067.65 | Form 4, filing 0001487371-17-000181 | |
| 2017-08-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 138 disposed | 10.33 | 1,425.54 | Form 4, filing 0001487371-17-000164 | |
| 2017-06-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 132 disposed | 12.89 | 1,701.48 | Form 4, filing 0001487371-17-000138 | |
| 2017-05-19 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 1,265 disposed | 12.89 | 16,305.85 | Form 4, filing 0001487371-17-000115 | |
| 2017-05-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 133 disposed | 13.34 | 1,774.22 | Form 4, filing 0001487371-17-000100 | |
| 2017-03-07 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 311 disposed | 12.18 | 3,787.98 | Form 4, filing 0001487371-17-000074 | |
| 2017-03-03 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 131 disposed | 12.29 | 1,609.99 | Form 4, filing 0001487371-17-000070 | |
| 2017-02-21 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 5,250 disposed | 10.08 | 52,920.00 | Form 4, filing 0001487371-17-000040 | |
| 2017-02-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 131 disposed | 11.58 | 1,516.98 | Form 4, filing 0001487371-17-000022 | |
| 2017-01-19 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 5,718 disposed | 12.47 | 71,303.46 | Form 4, filing 0001487371-17-000013 | |
| 2016-12-07 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 313 disposed | 11.08 | 3,468.04 | Form 4, filing 0001487371-16-000398 | |
| 2016-12-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 132 disposed | 11.30 | 1,491.60 | Form 4, filing 0001487371-16-000392 | |
| 2016-11-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 135 disposed | 10.30 | 1,390.50 | Form 4, filing 0001487371-16-000376 | |
| 2016-09-07 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 310 disposed | 8.69 | 2,693.90 | Form 4, filing 0001487371-16-000357 | |
| 2016-09-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 133 disposed | 8.62 | 1,146.46 | Form 4, filing 0001487371-16-000347 | |
| 2016-08-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 135 disposed | 9.88 | 1,333.80 | Form 4, filing 0001487371-16-000329 | |
| 2016-06-07 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 310 disposed | 8.98 | 2,783.80 | Form 4, filing 0001487371-16-000312 | |
| 2016-06-03 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 125 disposed | 8.53 | 1,066.25 | Form 4, filing 0001487371-16-000312 | |
| 2016-05-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 135 disposed | 5.79 | 781.65 | Form 4, filing 0001487371-16-000283 | |
| 2016-03-07 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 364 disposed | 5.76 | 2,096.64 | Form 4, filing 0001487371-16-000252 | |
| 2016-03-02 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 157 disposed | 4.87 | 764.59 | Form 4, filing 0001487371-16-000245 | |
| 2016-03-01 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 1,385 disposed | 4.93 | 6,828.05 | Form 4, filing 0001487371-16-000245 | |
| 2016-02-03 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 1,916 disposed | 4.99 | 9,560.84 | Form 4, filing 0001487371-16-000207 | |
| 2016-01-21 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 78 disposed | 6.80 | 530.40 | Form 4, filing 0001487371-16-000189 | |
| 2015-12-08 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 328 disposed | 7.26 | 2,381.28 | Form 4, filing 0001487371-15-000181 | |
| 2015-12-03 |
GenMark Diagnostics, Inc. GNMK |
S, Open-market sale | 132 disposed | 7.71 | 1,017.72 | Form 4, filing 0001487371-15-000174 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 15
- Open-market sale 72
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Kayyem Jon Faiz, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001366268
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6